Error: Could not add to watchlist. X
+ Watchlist

Protagonist Therapeutics Inc

PTGX:US
NASDAQ GM
12.00
USD
0.08
0.66%
As of 8:10 PM EDT 6/23/2017
Open
12.09
Day Range
11.81 - 12.09
Volume
267,963
Previous Close
12.08
52Wk Range
8.00 - 26.36
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
12.09
Day Range
11.81 - 12.09
Volume
267,963
Previous Close
12.08
52Wk Range
8.00 - 26.36
YTD Return
-45.43%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-21.40
Market Cap (m USD)
202.277
Shares Outstanding (m)
16.856
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Protagonist Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Protagonist Therapeutics serves customers worldwide.
Address
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035-7404
United States
Phone
1-408-649-7370
  • Dinesh V Patel
    President/CEO
  • Thomas P O'Neil "Tom"
    Chief Financial Officer
  • David Y Liu
    Chief Scientific Officer
  • Richard S Shames
    Chief Medical Officer
  • William A Hodder
    Senior VP:Corporate Dev
Show More